Save Job Back to Search Job Description Summary Similar JobsVeterans of China biotech founding teamFocusing on FIH to PoC programs in ChinaAbout Our ClientOur client is a clinical-stage biopharmaceutical company dedicated to advancing breakthrough therapies for genetic diseases. As an independent sister company to US Listed Partner, it was spun out in 2024 following a $300 million private financing round from external investors.Leveraging cutting-edge biological research, they are committed to discovering, developing, testing, and delivering transformative medicines for patients living with genetic diseases.Job DescriptionEstablish and implement IIT and CTA strategies in China tailored to indication and modality, to support early clinical development across multiple genetic medicine programs.Lead global clinical development for programs with first-in-human clinical trials initiated in China, including FIH and early PoC study design and execution; co-lead China site development for global trials involving Chinese sites.Act as a core member of global program teams, representing China clinical development and ensuring strong alignment with global development strategy, governance, and decision-making processes.Build and partner with cross-functional teams across Clinical, Regulatory, Safety, Biometrics, and CMC in both China and the U.S. to drive high-quality, compliant, and efficient clinical trial execution.Support due diligence and asset evaluation for China-originated assets and global programs with major China involvement within the GondolaBio / BridgeBio ecosystem.Develop and expand investigator, site, and CRO networks in China to enable rapid study startup, reliable trial execution, and scalable early clinical development capabilitiesThe Successful ApplicantM.D., M.D./Ph.D., or equivalent clinical doctoral degree.10+ years of clinical development experience, including 5+ years in senior leadership roles advancing programs through FIH and early-stage development; biotech background highly preferred.Demonstrated track record owning company-sponsored interventional trials and oversee IITs, with established investigator and site networks, CRO/vendor oversight, and full budget accountability.Experience serving as a core member of global development teams, directly contributing to program strategy, governance, and critical development decisions in English.Successful track record of advancing assets from IND through early Proof-of-Concept (PoC), with hands-on leadership in early clinical study design, execution, and data interpretation; pivotal-stage experience a plus.Strong clinical pharmacology and PK-PD orientation for early-stage development and dose-ranging decisions.Direct regulatory leadership experience, including pre-IND/IND meetings, written submissions, and safety-related communications.Demonstrated ability to build and scale lean, high-performing clinical organizations while mentoring and developing talent.What's on OfferCulture guided by core values: patient-centricity, independent thinking, radical transparency, efficiency, and science-driven decision-making.Decentralized operating model that empowers program teams to advance science and support patients, with an affiliate structure that reduces bureaucracy and places decision-making with those closest to the research.Competitive total compensation package including base salary, performance bonus, equity, and comprehezsive health, welfare, and retirement benefits.Flexible paid time offPartnerships with research and medical institutions.Strong commitment to Diversity, Equity & Inclusion.ContactMaria KarpQuote job refJN-012026-6914781Job summaryFunctionEngineering & ManufacturingSubsectorEngineering & Manufacturing SubsectorIndustryLife SciencesLocationChinaContract typePermanentConsultant nameMaria KarpJob referenceJN-012026-6914781
